DIAMPA LXR 10/5/1000MG TAB 1`S

DIAMPA LXR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains empagliflozin 10mg, linagliptin 5mg, and metformin HCl 1000mg—three potent ingredients working together to help regulate blood sugar levels. Empagliflozin works by increasing glucose excretion through urine, while linagliptin enhances insulin secretion and reduces glucagon levels. Metformin improves insulin sensitivity and decreases hepatic glucose production. This synergistic combination helps achieve better glycemic control in type 2 diabetes patients. Suitable for adults requiring multi-drug therapy. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight. Consult your doctor before use, especially if you have kidney or liver conditions. Not recommended during pregnancy or breastfeeding without medical guidance.